title: Type II versus Type III nerve-sparing radical hysterectomy: comparison of lower urinary tract dysfunctions.
abstract: OBJECTIVE
  According to our previous experience, Type III Nerve-sparing Radical hysterectomy (NSRH) for cervical cancer presented an acceptable urologic morbidity, without compromising radicality. The aim of this study was to compare Type NSRH with other types of RH in terms of incidence of early bladder dysfunctions and perioperative complications.
  
  
  METHODS
  One hundred and ten patients with cervical cancer were submitted to Type II RH (group 1), Type III NSRH (group 2) and Type III RH (group 3). We assessed the postoperative early bladder function and complications. The follow-up period was 3 months.
  
  
  RESULTS
  Group 1 had a significantly shorter duration of the surgery, minor mean blood loss and shorter mean length of postoperative stay when compared to groups 2 and 3. No intraoperative complications were reported in either of the groups. The groups did not differ significantly in terms of GIII/IV morbidity (group 1 = 10%, group 2 = 10% and group 3 = 15%, chi(2), P value: 0.65). Not even they differed in terms of urologic GI-IV morbidity (group 1 = 13%, group 2 = 15% and group 3 = 10%, chi(2), P value = 0.88). Groups 1 and 2 presented a prompt recover of bladder function, significantly different from that of group 3. There was a significant difference between the groups regarding the number of patients discharged with self-catheterism (group 1 = 0; group 2 and group 3 = 11; chi(2), P value << 0.05).
  
  
  CONCLUSIONS
  The Type III NSRH seems to be comparable to Type II RH and superior to Type III RH in terms of early bladder dysfunctions.
authors.affiliation: Department of Gynecologic Oncology, Istituto Nazionale Tumori, via Venezian 1, 20133 Milan, Italy.
authors.forename: Francesco
authors.initials: F
authors.lastname: Raspagliesi
authors.forename: Antonino
authors.initials: A
authors.lastname: Ditto
authors.forename: Rosanna
authors.initials: R
authors.lastname: Fontanelli
authors.forename: Flavia
authors.initials: F
authors.lastname: Zanaboni
authors.forename: Eugenio
authors.initials: E
authors.lastname: Solima
authors.forename: Gianbattista
authors.initials: G
authors.lastname: Spatti
authors.forename: Francesco
authors.initials: F
authors.lastname: Hanozet
authors.forename: Francesca
authors.initials: F
authors.lastname: Vecchione
authors.forename: Gabriella
authors.initials: G
authors.lastname: Rossi
authors.forename: Shigeki
authors.initials: S
authors.lastname: Kusamura
mesh_terms: D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D007044:Hysterectomy / Q000009:adverse effects / Q000379:methods*; D008875:Middle Aged; D012189:Retrospective Studies; D001743:Urinary Bladder / Q000294:innervation / Q000503:physiopathology; D001745:Urinary Bladder Diseases / Q000209:etiology* / Q000503:physiopathology; D002583:Uterine Cervical Neoplasms / Q000601:surgery*; D014599:Uterus / Q000276:immunology